There are 2949 resources available
1178P - Impact of comprehensive genomics profiling on treatment management of patients with advanced neuroendocrine neoplasms
Presenter: Alejandro Garcia-Alvarez
Session: E-Poster Display
Resources:
Abstract
1179P - Therapeutic sequences in advanced grade 1-2 pancreatic neuroendocriene tumours (pNET)
Presenter: Ilaria Maggio
Session: E-Poster Display
Resources:
Abstract
1180P - Single-institution real-life experience of 177Lu-DOTATATE treatment in progressive, well differentiated GEPNETs
Presenter: Federica Scalorbi
Session: E-Poster Display
Resources:
Abstract
1181P - Real-world data on neuroendocrine neoplasms (NENs): Preliminary results of an observational study by the Hellenic Society of Medical Oncology (HeSMO)
Presenter: Nikolaos Tsoukalas
Session: E-Poster Display
Resources:
Abstract
1182P - Baseline neutrophil-lymphocyte ratio and its variations after adjuvant radiotherapy predict clinical survival outcomes in locally advanced Merkel cell carcinoma (MCC)
Presenter: Martina Torchio
Session: E-Poster Display
Resources:
Abstract
1183P - Sequential PRRT and SIRT: Evaluation of safety, toxicity and best sequence treatment in liver dominant GEPNETs
Presenter: Federica Scalorbi
Session: E-Poster Display
Resources:
Abstract
1184P - A single-center retrospective analysis of patients with advanced G3 neuroendocrine tumours
Presenter: Alice Laffi
Session: E-Poster Display
Resources:
Abstract
1185P - [18F]FDG-PET/CT and long-term response to everolimus in advanced neuroendocrine neoplasia
Presenter: Maria Rinzivillo
Session: E-Poster Display
Resources:
Abstract
1186P - Impact of temozolomide (TEM) and capecitabine (CAP) dose reductions in toxicity and efficacy in patients (pts) with neuroendocrine neoplasms (NENs) treated with CAPTEM chemotherapy
Presenter: Jorge Hernando
Session: E-Poster Display
Resources:
Abstract
1187P - Characterization of the gastroenteropancreatic neuroendocrine tumour patient journey
Presenter: Val Nassiri
Session: E-Poster Display
Resources:
Abstract